<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20250726066634N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-10-14</date_registration>
      <primary_sponsor>Kharazmi University</primary_sponsor>
      <public_title>The effect of balance and cognitive balance exercises on improving balance and movements in children with cerebral palsy.</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of adding cognitive training to balance exercises on gait, motor performance, balance, brain activation pattern, quality of life, and fall risk in children with cerebral palsy.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-10-17</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>42</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/85510</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Participants will be allocated to three study groups using block randomization with fixed block size of 6 and an allocation ratio of 1:1:1. Considering the total sample size of 42 participants, randomization will be performed in 7 consecutive blocks (7×6=42).
In each block:
Two participants will be assigned to the cognitive–balance training group
Two participants will be assigned to the specific balance training group
Two participants will be assigned to the control group
The random sequence will be generated using the website Randomizer (https://www.randomizer.org/).
To ensure allocation concealment, each group assignment will be placed in opaque, sealed, and sequentially numbered envelopes.
After confirming eligibility and obtaining written informed consent from the parents or legal guardians, each participant will be given an envelope by an independent person who is not involved in data collection or intervention implementation. The participant will then be assigned to the group indicated inside the envelope.
This procedure ensures that participants enter the random sequence in a sequential and concealed manner, preventing any investigator or staff involved in the intervention or data collection from knowing the group assignment in advance, Blinding description: In this study, the outcome assessor will be blinded, so that they will not be aware of the participants’ group allocation. Participants, their parents, and the intervention administrators (therapists) will not be blinded, as it is necessary for them to perform and supervise the exercises.</study_design>
      <phase>N/A</phase>
      <hc_freetext>cerebral palsy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group 1 (Balance-Specific Training – BST):Participants in this group receive specialized balance training, including transfer exercises, static balance, and dynamic balance activities. The purpose of these exercises is to strengthen motor skills and improve balance control to reduce the risk of falls. Each session lasts 60 minutes and is conducted three times per week for 8 weeks. The intensity and difficulty of the exercises are gradually adjusted based on the child’s abilities. Intervention 2: Intervention group: Intervention Group 2 (Cognitive-Balance Training):Participants in this group perform combined motor and cognitive exercises. The exercises include cognitive tasks performed simultaneously with balance activities to improve motor control, balance, and cognitive function. Each session lasts 60 minutes and is conducted three times per week for 8 weeks. The exercises gradually become more challenging to maximize the child’s progress. Intervention 3: Control group: This group does not receive any intervention and only undergoes assessments before and after the research period.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Since the participants in this study are children with cerebral palsy, their individual and performance data are highly sensitive and confidential. Sharing individual participant data, even in a de-identified form, may conflict with ethical principles of research involving children and vulnerable populations. Therefore, to protect participants’ privacy and ensure ethical integrity, there is no plan to share individual participant data (IPD).</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nafise Bagheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Isfahan - Mirdamad Street - Alley No. 35 - Esteghlal Dead End - Omid Apartment</address>
        <city>Esfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8136937668</zip>
        <telephone>+98 31 3236 1511</telephone>
        <email>nafise.bagheri6411@gmail.com</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Malihe Haddadnejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Shahid Keshvari Complex, end of Shahid Hesari Street, end of Mirdamad, Faculty of Physical Education and Sports Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1544733111</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>m.hadadnezhad@yahoo.com</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Major inclusion criteria before randomization:                                          
 - Diagnosis of spastic cerebral palsy (CP) by a specialist physician  - Age range between 7 and 18 years                                                                 - Ability to understand and perform the proposed exercises and research tests                                                                                             - No participation in a similar training program during the past three months                                                                                                           - Written informed consent from parents or legal guardian                                   
- General good health (no severe chronic diseases or psychological disorders that prevent exercise participation)                                         - Gross Motor Function Classification System (GMFCS) levels I and II</inclusion_criteria>
      <agemin>7 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Major exclusion criteria before randomization :                                   
- Any surgery or medical conditions that prevent participation in exercises                                                                                                 - Lack of cooperation or unwillingness of the child or parents to participate in the study                                                                             

- Participation in similar training programs or other interventions that may interfere with study outcomes                                                     

- Occurrence of severe cognitive or motor problems that prevent continuing the exercises</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G80.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral palsy, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group 1 (Balance-Specific Training – BST):Participants in this group receive specialized balance training, including transfer exercises, static balance, and dynamic balance activities. The purpose of these exercises is to strengthen motor skills and improve balance control to reduce the risk of falls. Each session lasts 60 minutes and is conducted three times per week for 8 weeks. The intensity and difficulty of the exercises are gradually adjusted based on the child’s abilities.</i_keyword>
      <i_keyword>Intervention group: Intervention Group 2 (Cognitive-Balance Training):Participants in this group perform combined motor and cognitive exercises. The exercises include cognitive tasks performed simultaneously with balance activities to improve motor control, balance, and cognitive function. Each session lasts 60 minutes and is conducted three times per week for 8 weeks. The exercises gradually become more challenging to maximize the child’s progress.</i_keyword>
      <i_keyword>Control group: This group does not receive any intervention and only undergoes assessments before and after the research period.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance. Timepoint: Immediately before the intervention begins and immediately after the intervention ends. Method of measurement: Dynamic balance (TUG), static balance (modified Romberg), functional balance (PBS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Gait. Timepoint: Immediately before the intervention begins and immediately after the intervention ends. Method of measurement: Using 2D video analysis in Kinovea software (while walking).</sec_outcome>
      <sec_outcome>Gross Motor Function. Timepoint: Immediately before the intervention begins and immediately after the intervention ends. Method of measurement: Using the Gross Motor Function Measure-88 (GMFM-88) test, two of the five motor domains of this test (D to E) are measured.</sec_outcome>
      <sec_outcome>Brain activation pattern. Timepoint: Measurement of outcome variables is carried out in two time phases: 1- Before the start of the intervention (pre-test) 2- After the end of the intervention (post-test). Method of measurement: Using electroencephalography (EEG).</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: Immediately before the intervention begins and immediately after the intervention ends. Method of measurement: Persian-translated CP QOL-Child Quality of Life Questionnaire (based on age, either the patient or the patient's parents fill it out) Two questionnaire models based on age range.</sec_outcome>
      <sec_outcome>Fall Risk. Timepoint: Immediately before the intervention begins and immediately after the intervention ends. Method of measurement: Fall risk using the Dynamic Gait Index (DGI) test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kharazmi University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-06-26</approval_date>
        <contact_name>Ethics Committee of Kharrazmi University</contact_name>
        <contact_address>Kharazmi University, University Square, Shahid Beheshti Street, Karaj, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
